US FDA Shelves Commissioner's Voucher Program for Speedy Drug Reviews, Sources Say

The US FDA has reportedly shelved its fast-track drug review voucher program initiated during the Trump administration amid concerns over political influence and leadership instability. While some drugs received accelerated approval, no new vouchers have been awarded since former Commissioner Marty Makary departed.